D-0295-2026 Class II Ongoing
FDA drug recall D-0295-2026 was initiated by Zydus Pharmaceuticals (USA) Inc on Dec 30, 2025 and is designated Class II. Reason for recall: Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules The recall status is ongoing. Affected quantity: 22,896 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 28, 2026
- Initiation Date
- Dec 30, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22,896 bottles
Product description
Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07
Reason for recall
Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
Distribution pattern
US Nationwide.
Code information
Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0295-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026